GELBMAN RONALD G 4
4 · HAEMONETICS CORP · Filed Nov 17, 2017
Insider Transaction Report
Form 4
GELBMAN RONALD G
Director
Transactions
- Sale
Common Stock
2017-11-16$56.73/sh−400$22,692→ 55,117 total - Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2017-11-16−5,440→ 1,678 totalExercise: $34.41From: 2012-07-21Exp: 2018-07-21→ Common Stock (5,440 underlying) - Sale
Common Stock
2017-11-16$56.57/sh−65$3,677→ 59,392 total - Sale
Common Stock
2017-11-16$56.60/sh−200$11,320→ 58,957 total - Sale
Common Stock
2017-11-16$56.63/sh−200$11,326→ 58,517 total - Sale
Common Stock
2017-11-16$56.65/sh−400$22,660→ 58,117 total - Sale
Common Stock
2017-11-16$56.68/sh−300$17,004→ 57,317 total - Sale
Common Stock
2017-11-16$56.71/sh−100$5,671→ 55,617 total - Sale
Common Stock
2017-11-16$56.73/sh−300$17,021→ 54,817 total - Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2017-11-16−1,678→ 0 totalExercise: $34.41From: 2012-07-21Exp: 2018-07-21→ Common Stock (1,678 underlying) - Exercise/Conversion
Common Stock
2017-11-16$34.41/sh+5,440$187,163→ 59,457 total - Sale
Common Stock
2017-11-16$56.58/sh−235$13,296→ 59,157 total - Sale
Common Stock
2017-11-16$56.62/sh−240$13,589→ 58,717 total - Sale
Common Stock
2017-11-16$56.66/sh−100$5,666→ 58,017 total - Sale
Common Stock
2017-11-16$56.67/sh−300$17,001→ 57,617 total - Sale
Common Stock
2017-11-16$56.69/sh−400$22,676→ 56,917 total - Sale
Common Stock
2017-11-16$56.70/sh−1,200$68,040→ 55,717 total - Sale
Common Stock
2017-11-16$56.77/sh−300$17,031→ 54,517 total - Sale
Common Stock
2017-11-16$56.80/sh−300$17,040→ 54,017 total - Sale
Common Stock
2017-11-16$56.66/sh−100$5,667→ 57,917 total - Sale
Common Stock
2017-11-16$56.72/sh−100$5,672→ 55,517 total - Sale
Common Stock
2017-11-16$56.78/sh−200$11,356→ 54,317 total - Exercise/Conversion
Common Stock
2017-11-16$34.41/sh+1,678$57,732→ 55,695 total
Footnotes (1)
- [F1]Grant to reporting person of right to buy shares of common stock exercisable 100 percent on the first anniversary of the date of grant.